Analytical Data
-
Gene name
AADACL1
- Application
-
Alternative Names
Nceh1; Aadacl1; Kiaa1363; Neutral cholesterol ester hydrolase 1
-
Species
Mouse
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8BLF1
-
Expression Region
Partial
-
AA Sequence
Tag type will be determined during the manufacturing process.
-
Molecular Weight
45.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AADACL1 (Adenosine Deaminase-Associated Protein 1) is a member of the AADAC family, known for its role in lipid metabolism and potential implications in various diseases. Research has indicated that AADACL1 is involved in the hydrolysis of fatty acid amides, influencing the levels of bioactive lipid mediators, which can impact inflammatory responses and neurochemical pathways. Given its regulatory functions in lipid signaling and its association with metabolic disorders, AADACL1 has drawn attention as a potential therapeutic target. The recombinant protein forms of AADACL1 are essential for studying its enzymatic properties, substrate specificity, and physiological relevance. By understanding the structural and functional aspects of AADACL1, researchers aim to elucidate its role in disease mechanisms, particularly in metabolic diseases, neurodegenerative disorders, and inflammation. The production of AADACL1 recombinant proteins allows for comprehensive investigations into its interactions with various substrates, potential inhibitors, and the underlying biochemical pathways. This knowledge could pave the way for developing novel therapies that target AADACL1, potentially offering new interventions for diseases linked to lipid metabolism and inflammation. Thus, the study of AADACL1 and its recombinant proteins is crucial for advancing our understanding of lipid biology and its impact on health and disease.
